Select Language:
On July 14, a humanoid robot manufacturer based in China announced it secured nearly $200 million in a pre-IPO funding round. The company intends to utilize the capital to advance and commercialize its core technologies.
The funds will be directed toward enhancing the integration of the company’s large-brain and small-brain systems, combining artificial intelligence reasoning with motion control in an all-in-one setup. This effort aims to support the large-scale rollout of thousands of fully autonomous humanoid robots and to broaden the company’s global footprint, especially in key markets.
Founded in 2022, the company has raised approximately $400 million over the past six months, including $200 million in a Series B funding round completed in January.
Moving forward, the company plans to bolster its manufacturing and delivery infrastructure globally, with a particular focus on expanding in the Middle East, Europe, and other Asian regions. It also aims to foster an open ecosystem for developers around the world to promote innovation and accelerate the commercialization of embodied AI technologies.
Currently, the company offers two full-sized humanoid robots, LimX Oli and LimX Luna, along with Tron, a modular robot series designed for research organizations. The firm reports having received thousands of orders so far, with over half originating from overseas markets.
Funding activities in China’s embodied AI sector have seen a sharp increase this year, driven by steady advancements in AI, rising expectations of IPOs among leading robotics companies, and ongoing government support.
According to a venture capital research firm, total funding in this sector surged sixfold in the first half of the year compared to the same period last year, reaching CNY93.5 billion (roughly $13.8 billion). The number of financing deals also jumped 137 percent, totaling 322.




